Role of activin A in the induction of Foxp3+ and Foxp3- CD4+ regulatory T cells

Critical Reviews in Immunology

Volumn 31, Issue 1, 2011, Pages 53-60

  Huber, Samuel ^a,b   Schramm, Christoph ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Cytokines; Immune regulation; Regulatory T cells; Tolerance

Indexed keywords

ACTIVIN A; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3;

CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; HUMAN; LYMPHOCYTE DIFFERENTIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; THYMUS;

ACTIVINS; ANIMALS; CELL DIFFERENTIATION; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 79955647108     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunzia-ta N, Doetschman T. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal in-fammatory disease. Nature. 1992 Oct 22;359(6397):693-9.
2. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S. Transforming growth factor beta 1 null mutation in mice causes excessive infammatory response and early death. Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):770-4.
3. Gorelik L, Constant S, Flavell RA. Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med. 2002 Jun 3;195(11):1499-505.
4. Gorelik L, Fields PE, Flavell RA. Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol. 2000 Nov 1;165(9):4773-7.
5. Gorelik L, Flavell RA. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity. 2000 Feb;12(2):171-81.
6. - T cells through Foxp3 induction and down-regulation of Smad7. J Immunol. 2004 May 1;172(9):5149-53.
7. Huber S, Schramm C. TGF-beta and CD4+CD25+ regulatory T cells. Front Biosci. 2006 Jan 1;11:1014-23.
8. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med. 2003 Dec 15;198(12):1875-86.
9. + regulatory T cells. J Exp Med. 2005 Apr 4;201(7):1061-7.
10. + T cells. J Immunol. 2004 Dec 1;173(11):6526-31.
11. + T-cell pool and the expression of Foxp3 in vivo. Int Immunol. 2004 Sep;16(9):1241-9.
12. Li MO, Sanjabi S, Flavell RA. Transforming growth factor-beta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity. 2006 Sep;25(3):455-71.
13. Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity. 2007 May;26(5):579-91.
14. Phillips DJ, Jones KL, Scheerlinck JY, Hedger MP, de Kretser DM. Evidence for activin A and follistatin involvement in the systemic infammatory response. Mol Cell Endo-crinol. 2001 Jun 30;180(1-2):155-62.
15. Werner S, Alzheimer C. Roles of activin in tissue repair, f-brosis, and infammatory disease. Cytokine Growth Factor Rev. 2006 Jun;17(3):157-71.
16. Chen YG, Wang Q, Lin SL, Chang CD, Chuang J, Ying SY. Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis. Exp Biol Med (May-wood). 2006 May;231(5):534-44.
17. Petraglia F, Sacerdote P, Cossarizza A, Angioni S, Genazzani AD, Franceschi C, Muscettola M, Grasso G. Inhibin and activin modulate human monocyte chemotaxis and human lymphocyte interferon-gamma production. J Clin En-docrinol Metab. 1991 Feb;72(2):496-502.
18. Funaba M, Ikeda T, Ogawa K, Murakami M, Abe M. Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration. J Leukoc Biol. 2003 Jun;73(6):793-801.
19. Ogawa K, Funaba M, Mathews LS, Mizutani T. Activin A stimulates type IV collagenase (matrix metalloproteinase-2) production in mouse peritoneal macrophages. J Immunol. 2000 Sep 15;165(6):2997-3003.
20. Abe M, Shintani Y, Eto Y, Harada K, Kosaka M, Matsumoto T. Potent induction of activin A secretion from monocytes and bone marrow stromal fbroblasts by cognate interaction with activated T cells. J Leukoc Biol. 2002 Aug;72(2):347-52.
21. Cho SH, Yao Z, Wang SW, Alban RF, Barbers RG, French SW, Oh CK. Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J Immunol. 2003 Apr 15;170(8):4045-52.
22. Ogawa K, Funaba M, Chen Y, Tsujimoto M. Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages. J Immunol. 2006 Nov 15;177(10):6787-94.
23. Eramaa M, Hurme M, Stenman UH, Ritvos O. Activin A/erythroid differentiation factor is induced during human monocyte activation. J Exp Med. 1992 Nov 1;176(5):1449-52.
24. Shao L, Frigon NL, Jr., Sehy DW, Yu AL, Lofgren J, Schwall R, Yu J. Regulation of production of activin A in human marrow stromal cells and monocytes. Exp Hematol. 1992 Nov;20(10):1235-42.
25. Hubner G, Werner S. Serum growth factors and proinfam-matory cytokines are potent inducers of activin expression in cultured fbroblasts and keratinocytes. Exp Cell Res. 1996 Oct 10;228(1):106-13.
26. Shao LE, Frigon NL, Jr., Yu A, Palyash J, Yu J. Contrasting effects of infammatory cytokines and glucocorticoids on the production of activin A in human marrow stromal cells and their implications. Cytokine. 1998 Mar;10(3):227-35.
27. Abe M, Shintani Y, Eto Y, Harada K, Fujinaka Y, Kosaka M, Matsumoto T. Interleukin-1 beta enhances and interferon-gamma suppresses activin A actions by reciprocally regulating activin A and follistatin secretion from bone marrow stromal fbroblasts. Clin Exp Immunol. 2001 Oct;126(1):64-8.
28. Okuma Y, Saito K, O'Connor AE, Phillips DJ, de Kretser DM, Hedger MP. Reciprocal regulation of activin A and in-hibin B by interleukin-1 (IL-1) and follicle-stimulating hormone (FSH) in rat Sertoli cells in vitro. J Endocrinol. 2005 Apr;185(1):99-110.
29. Yu J, Shao LE, Frigon NL, Jr., Lofgren J, Schwall R. Induced expression of the new cytokine, activin A, in human monocytes: inhibition by glucocorticoids and retinoic acid. Immunology. 1996 Jul;88(3):368-74.
30. Yamashita N, Nakajima T, Takahashi H, Kaneoka H, Miz-ushima Y, Sakane T. Effects of activin A on IgE synthesis and cytokine production by human peripheral mononuclear cells. Clin Exp Immunol. 1993 Oct;94(1):214-9.
31. Nusing RM, Barsig J. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A. Br J Pharmacol. 1999 Jun;127(4):919-26.
32. Hedger MP, Phillips DJ, de Kretser DM. Divergent cell-specifc effects of activin-A on thymocyte proliferation stimulated by phytohemagglutinin, and interleukin 1beta or inter-leukin 6 in vitro. Cytokine. 2000 Jun;12(6):595-602.
33. Brosh N, Sternberg D, Honigwachs-Sha'anani J, Lee BC, Shav-Tal Y, Tzehoval E, Shulman LM, Toledo J, Hacham Y, Carmi P, Jiang W, Sasse J, Horn F, Burstein Y, Zipori D. The plasmacytoma growth inhibitor restrictin-P is an antagonist of interleukin 6 and interleukin 11. Identifca-tion as a stroma-derived activin A. J Biol Chem. 1995 Dec 8;270(49):29594-600.
34. Russell CE, Hedger MP, Brauman JN, de Kretser DM, Phillips DJ. Activin A regulates growth and acute phase proteins in the human liver cell line, HepG2. Mol Cell Endocrinol. 1999 Feb 25;148(1-2):129-36.
35. Yu EW, Dolter KE, Shao LE, Yu J. Suppression of IL-6 biological activities by activin A and implications for infammatory arthropathies. Clin Exp Immunol. 1998 Apr;112(1):126-32.
36. Ohguchi M, Yamato K, Ishihara Y, Koide M, Ueda N, Oka-hashi N, Noguchi T, Kizaki M, Ikeda Y, Sugino H, Nisihara T. Activin A regulates the production of mature interleukin-1beta and interleukin-1 receptor antagonist in human mono-cytic cells. J Interferon Cytokine Res. 1998 Jul;18(7):491-8.
37. Huber S, Stahl FR, Schrader J, Luth S, Presser K, Carambia A, Flavell RA, Werner S, Blessing M, Herkel J, Schramm C. Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells. J Immunol. 2009 Apr 15;182(8):4633-40.
38. Semitekolou M, Alissaf T, Aggelakopoulou M, Kourepini E, Kariyawasam HH, Kay AB, Robinson DS, Lloyd CM, Panoutsakopoulou V, Xanthou G. Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease. J Exp Med. 2009 Aug 3;206(8):1769-85.
39. -/- mice: in vivo suppression by CD4+CD25+ regulatory T cells independent of autocrine TGF-beta1. Blood. 2004 Jun 15;103(12):4594-601.
40. Luth S, Huber S, Schramm C, Buch T, Zander S, Stadel-mann C, Bruck W, Wraith DC, Herkel J, Lohse AW. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinfammation by inducing antigen-specifc Tregs. J Clin Invest. 2008 Oct 1;118(10):3403-10.
41. Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nus-senzweig MC, von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol. 2005 Dec;6(12):1219-27.
42. Hawiger D, Wan YY, Eynon EE, Flavell RA. The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell-mediated peripheral T cell unresponsive-ness. Nat Immunol. 2010 Oct;11(10):962-8.
43. Ziegler SF. FOXP3: of mice and men. Annu Rev Immunol. 2006;24:209-26.
44. + suppressor T cells: more questions than answers. Nat Rev Immunol. 2002 Jun;2(6):389-400.
45. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol. 2005 Apr;6(4):345-52.
46. Fontenot JD, Rudensky AY. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol. 2005 Apr;6(4):331-7.
47. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol. 2003 Mar;3(3):199-210.
48. + and type 1 regulatory T cells. Curr Top Microbiol Immunol. 2005;293:303-26.
49. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleis-chhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev. 2006 Aug;212:28-50.
50. Roncarolo MG, Battaglia M. Regulatory T-cell immuno-therapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol. 2007 Aug;7(8):585-98.
51. ten Dijke P, Hill CS. New insights into TGF-beta-Smad signalling. Trends Biochem Sci. 2004 May;29(5):265-73.
52. Attisano L, Wrana JL, Montalvo E, Massague J. Activation of signalling by the activin receptor complex. Mol Cell Biol. 1996 Mar;16(3):1066-73.
53. de Guise C, Lacerte A, Rafei S, Reynaud R, Roy M, Brue T, Lebrun JJ. Activin inhibits the human Pit-1 gene promoter through the p38 kinase pathway in a Smad-independent manner. Endocrinology. 2006 Sep;147(9):4351-62.
54. Gorelik L, Flavell RA. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol. 2002 Jan;2(1):46-53.
55. Yu L, Hebert MC, Zhang YE. TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. Embo J. 2002 Jul 15;21(14):3749-59.
56. Krummen LA, Woodruff TK, DeGuzman G, Cox ET, Baly DL, Mann E, Garg S, Wong WL, Cossum P, Mather JP. Identifcation and characterization of binding proteins for inhibin and activin in human serum and follicular fuids. Endocrinology. 1993 Jan;132(1):431-43.
57. Licona-Limon P, Aleman-Muench G, Chimal-Monroy J, Macias-Silva M, Garcia-Zepeda EA, Matzuk MM, Fortoul TI, Soldevila G. Activins and inhibins: novel regulators of thymocyte development. Biochem Biophys Res Commun. 2009 Apr 3;381(2):229-35.
58. Licona-Limon P, Soldevila G. The role of TGF-beta super-family during T cell development: new insights. Immunol Lett. 2007 Mar 15;109(1):1-12.
59. Licona P, Chimal-Monroy J, Soldevila G. Inhibins are the major activin ligands expressed during early thymocyte development. Dev Dyn. 2006 Apr;235(4):1124-32.
60. Ouyang W, Beckett O, Ma Q, Li MO. Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity. 2010 May 28;32(5):642-53.
61. -T cells into iTreg. PLoS One. 2008;3(10):e3302.
62. Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol. 2008 Feb;9(2):194-202.
63. Munz B, Smola H, Engelhardt F, Bleuel K, Brauchle M, Lein I, Evans LW, Huylebroeck D, Balling R, Werner S. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fbrosis and wound repair. Embo J. 1999 Oct 1;18(19):5205-15.
64. Rosendahl A, Checchin D, Fehniger TE, ten Dijke P, Hel-din CH, Sideras P. Activation of the TGF-beta/activin-Smad2 pathway during allergic airway infammation. Am J Respir Cell Mol Biol. 2001 Jul;25(1):60-8.
65. Hardy CL, O'Connor AE, Yao J, Sebire K, de Kretser DM, Rolland JM, Anderson GP, Phillips DJ, O'Hehir RE. Fol-listatin is a candidate endogenous negative regulator of ac-tivin A in experimental allergic asthma. Clin Exp Allergy. 2006 Jul;36(7):941-50.
66. Karagiannidis C, Hense G, Martin C, Epstein M, Ruckert B, Mantel PY, Menz G, Uhlig S, Blaser K, Schmidt-Weber CB. Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. J Allergy Clin Immunol. 2006 Jan;117(1):111-8.
67. Ogawa K, Funaba M, Tsujimoto M. A dual role of activin A in regulating immunoglobulin production of B cells. J Leukoc Biol. 2008 Jun;83(6):1451-8.
68. Hogan BL. Bone morphogenetic proteins in development. Curr Opin Genet Dev. 1996 Aug;6(4):432-8.
69. Bleul CC, Boehm T. BMP signaling is required for normal thymus development. J Immunol. 2005 Oct 15;175(8):5213-21.
70. Bhatia M, Bonnet D, Wu D, Murdoch B, Wrana J, Gal-lacher L, Dick JE. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med. 1999 Apr 5;189(7):1139-48.
71. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 2003 Jun 13;113(6):685-700.
72. Massague J. TGF-beta signal transduction. Annu Rev Bio-chem. 1998;67:753-91.
73. Attisano L, Wrana JL. Smads as transcriptional co-modulators. Curr Opin Cell Biol. 2000 Apr;12(2):235-43.
74. + Treg. Eur J Immunol. 2010 Jan;40(1):142-52.
75. Sivertsen EA, Huse K, Hystad ME, Kersten C, Smeland EB, Myklebust JH. Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells. Eur J Immunol. 2007 Oct;37(10):2937-48.